Health
Study shows vaccine’s potential to stop viral spread – The Australian Financial Review
The news is potentially good for Australia as the Oxford-AstraZeneca vaccine is being manufactured onshore by CSL.
The study design focused on the interval between the two jabs and how this affected the level of protection against becoming ill with COVID-19.
But it covered transmission too, as the Oxford University newsletter explains:
The authors also report further on the potential for the vaccine to reduce transmission of the virus, based on swabs obtained from volunteers in the UK arms of the trial with a 67 per cent reduction after the first dose of the vaccine.
But they say the data is preliminary and…
-
Business21 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
Business6 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
General11 hours agoVolodymyr Zelenskyy claims Chinese soldiers fighting alongside Russians in Ukraine
-
General18 hours agoHow what happens on financial markets affects the broader economy